It would be thus important to screen the PRL, PRLR and dopamine receptor DR1D, DR2D, DR3D, DR4D and DR5D genes in both T2D and SCZ families and case–control groups. The gene discussed is PRLR; the disease is type 2 diabetes mellitus.